| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 54 | 2023 | 131 | 14.010 |
Why?
|
| Obesity, Morbid | 46 | 2022 | 121 | 10.760 |
Why?
|
| Obesity | 53 | 2022 | 814 | 9.630 |
Why?
|
| Gastric Bypass | 33 | 2022 | 72 | 7.200 |
Why?
|
| Weight Loss | 35 | 2022 | 295 | 5.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 23 | 2024 | 666 | 4.480 |
Why?
|
| Humans | 138 | 2024 | 17376 | 3.050 |
Why?
|
| Male | 88 | 2024 | 9843 | 2.500 |
Why?
|
| Postoperative Complications | 12 | 2022 | 102 | 2.420 |
Why?
|
| Body Mass Index | 33 | 2022 | 937 | 2.320 |
Why?
|
| Female | 96 | 2024 | 12444 | 2.240 |
Why?
|
| Decision Support Techniques | 7 | 2016 | 86 | 2.230 |
Why?
|
| Veterans | 11 | 2022 | 145 | 2.190 |
Why?
|
| Middle Aged | 74 | 2024 | 7885 | 2.090 |
Why?
|
| Gastrectomy | 19 | 2022 | 47 | 2.030 |
Why?
|
| Decision Making | 5 | 2023 | 172 | 1.980 |
Why?
|
| Life Style | 6 | 2017 | 316 | 1.760 |
Why?
|
| Laparoscopy | 12 | 2022 | 46 | 1.720 |
Why?
|
| Adult | 63 | 2022 | 7529 | 1.590 |
Why?
|
| Retrospective Studies | 36 | 2022 | 2428 | 1.570 |
Why?
|
| Appetite Depressants | 8 | 2019 | 16 | 1.450 |
Why?
|
| Electronic Health Records | 8 | 2021 | 707 | 1.450 |
Why?
|
| Aged | 42 | 2022 | 6129 | 1.420 |
Why?
|
| Treatment Outcome | 26 | 2022 | 1170 | 1.400 |
Why?
|
| United States | 34 | 2022 | 3891 | 1.290 |
Why?
|
| Depression | 7 | 2022 | 487 | 1.180 |
Why?
|
| Health Expenditures | 6 | 2019 | 73 | 1.170 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 533 | 1.110 |
Why?
|
| Washington | 15 | 2017 | 385 | 1.110 |
Why?
|
| Health Care Costs | 7 | 2022 | 211 | 1.110 |
Why?
|
| Cohort Studies | 23 | 2022 | 2526 | 1.100 |
Why?
|
| Gastroplasty | 5 | 2016 | 10 | 1.090 |
Why?
|
| Dyslipidemias | 4 | 2022 | 56 | 1.080 |
Why?
|
| Weight Gain | 4 | 2016 | 156 | 1.010 |
Why?
|
| Insurance, Health | 5 | 2019 | 175 | 0.990 |
Why?
|
| Patient Participation | 3 | 2023 | 123 | 0.990 |
Why?
|
| Antidepressive Agents | 4 | 2016 | 142 | 0.920 |
Why?
|
| Blood Glucose | 4 | 2016 | 315 | 0.860 |
Why?
|
| Bariatrics | 2 | 2020 | 5 | 0.860 |
Why?
|
| Exercise | 5 | 2021 | 513 | 0.840 |
Why?
|
| Diabetes Mellitus | 4 | 2021 | 455 | 0.810 |
Why?
|
| Phentermine | 4 | 2019 | 10 | 0.810 |
Why?
|
| Statistics as Topic | 2 | 2021 | 57 | 0.780 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 263 | 0.780 |
Why?
|
| Patient Education as Topic | 3 | 2013 | 193 | 0.780 |
Why?
|
| Hypertension | 4 | 2020 | 469 | 0.770 |
Why?
|
| Insurance Coverage | 4 | 2022 | 103 | 0.750 |
Why?
|
| Follow-Up Studies | 16 | 2022 | 1155 | 0.740 |
Why?
|
| Depressive Disorder | 2 | 2015 | 185 | 0.710 |
Why?
|
| Health Promotion | 3 | 2014 | 278 | 0.690 |
Why?
|
| Motivation | 2 | 2014 | 116 | 0.670 |
Why?
|
| Comorbidity | 7 | 2016 | 564 | 0.650 |
Why?
|
| Prescription Drugs | 1 | 2019 | 31 | 0.610 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 47 | 0.610 |
Why?
|
| Confounding Factors (Epidemiology) | 1 | 2019 | 84 | 0.610 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 74 | 0.600 |
Why?
|
| Young Adult | 15 | 2021 | 2473 | 0.590 |
Why?
|
| Prevalence | 8 | 2021 | 839 | 0.590 |
Why?
|
| Health Status Disparities | 3 | 2019 | 148 | 0.590 |
Why?
|
| Telemedicine | 1 | 2021 | 182 | 0.560 |
Why?
|
| Logistic Models | 12 | 2016 | 884 | 0.550 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 200 | 0.520 |
Why?
|
| Neoplasms | 2 | 2017 | 448 | 0.510 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 81 | 0.510 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 18 | 0.500 |
Why?
|
| Health Services Accessibility | 2 | 2018 | 274 | 0.480 |
Why?
|
| Adolescent | 14 | 2022 | 3533 | 0.470 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 49 | 0.470 |
Why?
|
| Prostatic Hyperplasia | 1 | 2015 | 24 | 0.460 |
Why?
|
| Congresses as Topic | 1 | 2014 | 13 | 0.460 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 34 | 0.460 |
Why?
|
| Patient Care Planning | 1 | 2015 | 45 | 0.460 |
Why?
|
| Vagus Nerve | 1 | 2014 | 2 | 0.460 |
Why?
|
| Nerve Block | 1 | 2014 | 3 | 0.460 |
Why?
|
| Endpoint Determination | 1 | 2014 | 10 | 0.460 |
Why?
|
| Motor Activity | 2 | 2014 | 208 | 0.460 |
Why?
|
| Confidentiality | 1 | 2014 | 25 | 0.450 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 28 | 0.440 |
Why?
|
| Delivery of Health Care | 5 | 2022 | 395 | 0.440 |
Why?
|
| Amputation, Traumatic | 1 | 2014 | 1 | 0.440 |
Why?
|
| Amputees | 1 | 2014 | 1 | 0.440 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 251 | 0.430 |
Why?
|
| Risk Assessment | 10 | 2020 | 1079 | 0.430 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 63 | 0.430 |
Why?
|
| Social Class | 1 | 2014 | 117 | 0.430 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 44 | 0.430 |
Why?
|
| Weight Reduction Programs | 2 | 2014 | 49 | 0.420 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 82 | 0.420 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 148 | 0.420 |
Why?
|
| Risk Factors | 14 | 2021 | 3255 | 0.410 |
Why?
|
| Quality of Life | 5 | 2014 | 505 | 0.410 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 977 | 0.410 |
Why?
|
| Anti-Obesity Agents | 4 | 2019 | 18 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 118 | 0.410 |
Why?
|
| Counseling | 2 | 2022 | 173 | 0.400 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 1287 | 0.400 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 65 | 0.400 |
Why?
|
| Patients | 1 | 2013 | 31 | 0.400 |
Why?
|
| Cyclobutanes | 4 | 2005 | 5 | 0.400 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2012 | 11 | 0.400 |
Why?
|
| Quality of Health Care | 1 | 2015 | 279 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2012 | 17 | 0.390 |
Why?
|
| Health Behavior | 3 | 2013 | 345 | 0.390 |
Why?
|
| Hospitals, Veterans | 5 | 2013 | 31 | 0.390 |
Why?
|
| Reoperation | 4 | 2021 | 23 | 0.380 |
Why?
|
| Patient Selection | 1 | 2013 | 178 | 0.380 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 537 | 0.380 |
Why?
|
| Coronary Disease | 4 | 2019 | 146 | 0.380 |
Why?
|
| Risk | 5 | 2018 | 498 | 0.370 |
Why?
|
| Postoperative Care | 3 | 2020 | 17 | 0.370 |
Why?
|
| Proportional Hazards Models | 5 | 2019 | 702 | 0.370 |
Why?
|
| Videotape Recording | 1 | 2011 | 9 | 0.360 |
Why?
|
| Pamphlets | 1 | 2011 | 7 | 0.360 |
Why?
|
| Overweight | 3 | 2019 | 266 | 0.360 |
Why?
|
| Psychotherapy, Group | 1 | 2010 | 20 | 0.350 |
Why?
|
| Time Factors | 9 | 2021 | 1044 | 0.340 |
Why?
|
| Hypolipidemic Agents | 1 | 2010 | 38 | 0.340 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 1942 | 0.320 |
Why?
|
| Body Weight | 4 | 2006 | 203 | 0.320 |
Why?
|
| Mood Disorders | 1 | 2009 | 16 | 0.320 |
Why?
|
| Feeding and Eating Disorders | 1 | 2009 | 16 | 0.320 |
Why?
|
| Recurrence | 4 | 2022 | 165 | 0.320 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 31 | 0.300 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 92 | 0.300 |
Why?
|
| Occupational Health Services | 1 | 2008 | 12 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 316 | 0.290 |
Why?
|
| Depressive Disorder, Major | 3 | 2017 | 100 | 0.280 |
Why?
|
| Data Collection | 3 | 2021 | 240 | 0.280 |
Why?
|
| Case-Control Studies | 4 | 2016 | 1100 | 0.280 |
Why?
|
| Cost-Benefit Analysis | 3 | 2018 | 226 | 0.270 |
Why?
|
| Diabetes Complications | 2 | 2020 | 106 | 0.270 |
Why?
|
| Databases, Factual | 5 | 2019 | 306 | 0.270 |
Why?
|
| Attitude to Health | 1 | 2008 | 148 | 0.260 |
Why?
|
| Diet, Reducing | 1 | 2006 | 22 | 0.260 |
Why?
|
| Patient-Centered Care | 4 | 2021 | 190 | 0.260 |
Why?
|
| Residence Characteristics | 2 | 2024 | 253 | 0.250 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 609 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2013 | 366 | 0.250 |
Why?
|
| Health Personnel | 2 | 2023 | 126 | 0.250 |
Why?
|
| Remission Induction | 3 | 2016 | 26 | 0.240 |
Why?
|
| Censuses | 3 | 2014 | 29 | 0.240 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 538 | 0.240 |
Why?
|
| Amputation | 2 | 2015 | 11 | 0.230 |
Why?
|
| Propensity Score | 3 | 2015 | 82 | 0.230 |
Why?
|
| Medicare | 4 | 2022 | 201 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2018 | 380 | 0.230 |
Why?
|
| Life Expectancy | 3 | 2015 | 34 | 0.220 |
Why?
|
| Survival Rate | 2 | 2015 | 253 | 0.220 |
Why?
|
| Lactones | 4 | 2005 | 11 | 0.220 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 300 | 0.220 |
Why?
|
| Age Distribution | 3 | 2014 | 239 | 0.220 |
Why?
|
| Food | 1 | 2024 | 36 | 0.220 |
Why?
|
| Cause of Death | 3 | 2015 | 175 | 0.220 |
Why?
|
| Bayes Theorem | 2 | 2014 | 73 | 0.210 |
Why?
|
| Odds Ratio | 3 | 2016 | 644 | 0.210 |
Why?
|
| Interviews as Topic | 3 | 2016 | 304 | 0.210 |
Why?
|
| Incidence | 2 | 2017 | 1266 | 0.200 |
Why?
|
| Evidence-Based Medicine | 2 | 2002 | 171 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2022 | 1229 | 0.200 |
Why?
|
| Fluoxetine | 4 | 2013 | 17 | 0.200 |
Why?
|
| Cluster Analysis | 2 | 2014 | 86 | 0.190 |
Why?
|
| Geography | 2 | 2013 | 39 | 0.190 |
Why?
|
| Qualitative Research | 2 | 2014 | 262 | 0.190 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 11 | 0.190 |
Why?
|
| Insurance Claim Review | 2 | 2021 | 55 | 0.180 |
Why?
|
| Patient Safety | 1 | 2021 | 38 | 0.180 |
Why?
|
| Communication | 1 | 2023 | 181 | 0.180 |
Why?
|
| Colorectal Neoplasms | 2 | 2018 | 627 | 0.180 |
Why?
|
| Pandemics | 2 | 2021 | 285 | 0.180 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 198 | 0.180 |
Why?
|
| European Continental Ancestry Group | 2 | 2013 | 480 | 0.180 |
Why?
|
| Glycated Hemoglobin A | 3 | 2022 | 184 | 0.180 |
Why?
|
| Survival Analysis | 3 | 2011 | 203 | 0.180 |
Why?
|
| Prognosis | 3 | 2020 | 604 | 0.180 |
Why?
|
| Mortality | 2 | 2011 | 116 | 0.170 |
Why?
|
| Hernia, Hiatal | 1 | 2020 | 1 | 0.170 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2020 | 8 | 0.170 |
Why?
|
| Diethylpropion | 3 | 2005 | 3 | 0.170 |
Why?
|
| Mazindol | 3 | 2005 | 3 | 0.170 |
Why?
|
| Health Status | 2 | 2014 | 295 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2022 | 405 | 0.170 |
Why?
|
| Thromboembolism | 1 | 2000 | 32 | 0.170 |
Why?
|
| Bias | 2 | 2021 | 100 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.160 |
Why?
|
| Machine Learning | 1 | 2020 | 53 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.160 |
Why?
|
| Behavior Therapy | 2 | 2011 | 126 | 0.150 |
Why?
|
| Lower Extremity | 2 | 2015 | 12 | 0.150 |
Why?
|
| Ethnic Groups | 2 | 2019 | 456 | 0.140 |
Why?
|
| Age Factors | 3 | 2015 | 884 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2016 | 218 | 0.140 |
Why?
|
| Diet | 2 | 2021 | 356 | 0.140 |
Why?
|
| Alcoholism | 1 | 2020 | 337 | 0.130 |
Why?
|
| Orthopedics | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cancer Survivors | 1 | 2018 | 101 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2017 | 381 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 47 | 0.130 |
Why?
|
| Diabetic Angiopathies | 1 | 2016 | 31 | 0.130 |
Why?
|
| Cardiology | 1 | 2016 | 28 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2014 | 280 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 145 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2016 | 65 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2016 | 16 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 18 | 0.120 |
Why?
|
| Inflammation | 1 | 2016 | 63 | 0.120 |
Why?
|
| Thiazoles | 1 | 2015 | 10 | 0.120 |
Why?
|
| Piperazines | 1 | 2015 | 9 | 0.120 |
Why?
|
| Confidence Intervals | 2 | 2013 | 231 | 0.120 |
Why?
|
| Mental Health | 1 | 2017 | 168 | 0.120 |
Why?
|
| Benzodiazepines | 1 | 2015 | 28 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2015 | 20 | 0.120 |
Why?
|
| Polypharmacy | 1 | 2015 | 13 | 0.120 |
Why?
|
| Phenotype | 1 | 2015 | 148 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 26 | 0.120 |
Why?
|
| Accelerometry | 1 | 2015 | 51 | 0.110 |
Why?
|
| Malnutrition | 1 | 2014 | 2 | 0.110 |
Why?
|
| Small-Area Analysis | 1 | 2014 | 4 | 0.110 |
Why?
|
| Population Density | 1 | 2014 | 7 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 124 | 0.110 |
Why?
|
| Intention | 1 | 2014 | 29 | 0.110 |
Why?
|
| Spatial Analysis | 1 | 2014 | 11 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 128 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2014 | 35 | 0.110 |
Why?
|
| Contraception Behavior | 1 | 2014 | 16 | 0.110 |
Why?
|
| Pregnancy, Unplanned | 1 | 2014 | 7 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 32 | 0.110 |
Why?
|
| Phenylpropanolamine | 2 | 2004 | 2 | 0.110 |
Why?
|
| Food Supply | 1 | 2014 | 39 | 0.110 |
Why?
|
| Leg | 1 | 2014 | 3 | 0.110 |
Why?
|
| Fitness Centers | 1 | 2014 | 10 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2014 | 163 | 0.110 |
Why?
|
| Focus Groups | 1 | 2014 | 144 | 0.100 |
Why?
|
| Environment | 1 | 2013 | 50 | 0.100 |
Why?
|
| Income | 1 | 2013 | 87 | 0.100 |
Why?
|
| Registries | 2 | 2016 | 460 | 0.100 |
Why?
|
| Body Height | 1 | 2013 | 60 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2013 | 45 | 0.100 |
Why?
|
| Fasting | 1 | 2013 | 46 | 0.100 |
Why?
|
| Suicide | 1 | 2014 | 116 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 1 | 2012 | 8 | 0.100 |
Why?
|
| Cost Control | 1 | 2012 | 16 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2012 | 11 | 0.100 |
Why?
|
| Surveys and Questionnaires | 5 | 2018 | 1287 | 0.100 |
Why?
|
| Health Maintenance Organizations | 1 | 2014 | 408 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2015 | 273 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 205 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2010 | 140 | 0.090 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 56 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 197 | 0.090 |
Why?
|
| Conflict (Psychology) | 1 | 2011 | 6 | 0.090 |
Why?
|
| Uncertainty | 1 | 2011 | 5 | 0.090 |
Why?
|
| Health Surveys | 2 | 2011 | 250 | 0.090 |
Why?
|
| Social Values | 1 | 2011 | 14 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2011 | 67 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 226 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2011 | 173 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 114 | 0.090 |
Why?
|
| Energy Intake | 1 | 2010 | 98 | 0.080 |
Why?
|
| Women's Health | 1 | 2011 | 197 | 0.080 |
Why?
|
| Urban Health | 1 | 2010 | 36 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2010 | 93 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 424 | 0.080 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2010 | 216 | 0.080 |
Why?
|
| Primary Health Care | 2 | 2022 | 729 | 0.080 |
Why?
|
| Linear Models | 2 | 2010 | 210 | 0.080 |
Why?
|
| Workplace | 1 | 2008 | 29 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 677 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 131 | 0.070 |
Why?
|
| Perception | 1 | 2007 | 56 | 0.070 |
Why?
|
| Child | 2 | 2010 | 2382 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2020 | 81 | 0.070 |
Why?
|
| United Kingdom | 1 | 2006 | 25 | 0.060 |
Why?
|
| Television | 1 | 2006 | 16 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 1375 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2018 | 37 | 0.060 |
Why?
|
| Forecasting | 1 | 2004 | 69 | 0.060 |
Why?
|
| Heart Rate | 1 | 2004 | 38 | 0.060 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2004 | 46 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 439 | 0.050 |
Why?
|
| Markov Chains | 2 | 2015 | 22 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 196 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2004 | 275 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 343 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2001 | 5 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 6 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 15 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 18 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2001 | 25 | 0.050 |
Why?
|
| Pleasure | 1 | 2021 | 4 | 0.040 |
Why?
|
| Craving | 1 | 2021 | 9 | 0.040 |
Why?
|
| Selection Bias | 1 | 2021 | 18 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 2021 | 20 | 0.040 |
Why?
|
| Food Preferences | 1 | 2021 | 24 | 0.040 |
Why?
|
| Internet | 1 | 2022 | 212 | 0.040 |
Why?
|
| Herniorrhaphy | 1 | 2020 | 2 | 0.040 |
Why?
|
| Ohio | 1 | 2020 | 23 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2020 | 26 | 0.040 |
Why?
|
| Organs at Risk | 1 | 2020 | 1 | 0.040 |
Why?
|
| Probability | 1 | 2000 | 72 | 0.040 |
Why?
|
| Premenopause | 1 | 2020 | 24 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 25 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 127 | 0.040 |
Why?
|
| Minority Groups | 1 | 2019 | 103 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 259 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2019 | 52 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 248 | 0.040 |
Why?
|
| Stroke | 1 | 2001 | 310 | 0.040 |
Why?
|
| Cost Sharing | 1 | 2018 | 29 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 246 | 0.030 |
Why?
|
| Smoking | 2 | 2011 | 428 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 2 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 21 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 72 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 157 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2016 | 128 | 0.030 |
Why?
|
| Drug Costs | 1 | 2015 | 32 | 0.030 |
Why?
|
| Insulin | 1 | 2016 | 190 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2015 | 29 | 0.030 |
Why?
|
| Health | 1 | 2014 | 32 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 135 | 0.030 |
Why?
|
| Morbidity | 1 | 2014 | 59 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2014 | 56 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 88 | 0.030 |
Why?
|
| Mianserin | 1 | 2013 | 1 | 0.030 |
Why?
|
| Models, Economic | 1 | 2013 | 17 | 0.030 |
Why?
|
| Paroxetine | 1 | 2013 | 14 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 607 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2013 | 56 | 0.020 |
Why?
|
| Centers for Disease Control and Prevention (U.S.) | 1 | 2011 | 32 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2011 | 60 | 0.020 |
Why?
|
| Idaho | 1 | 2011 | 24 | 0.020 |
Why?
|
| Methods | 1 | 2010 | 4 | 0.020 |
Why?
|
| Ownership | 1 | 2010 | 14 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2010 | 47 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 34 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 805 | 0.020 |
Why?
|
| Self Report | 1 | 2011 | 257 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 1466 | 0.020 |
Why?
|
| Mammography | 1 | 2010 | 168 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 278 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2006 | 1 | 0.020 |
Why?
|
| Current Procedural Terminology | 1 | 2006 | 2 | 0.020 |
Why?
|
| Length of Stay | 1 | 2006 | 171 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 169 | 0.020 |
Why?
|
| Mass Screening | 1 | 2010 | 671 | 0.010 |
Why?
|